| __timestamp | Catalent, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 598600000 | 1162636000 |
| Thursday, January 1, 2015 | 615300000 | 1396725000 |
| Friday, January 1, 2016 | 587600000 | 1526100000 |
| Sunday, January 1, 2017 | 654600000 | 1619600000 |
| Monday, January 1, 2018 | 752600000 | 1429100000 |
| Tuesday, January 1, 2019 | 805100000 | 1331200000 |
| Wednesday, January 1, 2020 | 983300000 | 1375200000 |
| Friday, January 1, 2021 | 1352000000 | 1563000000 |
| Saturday, January 1, 2022 | 1640000000 | 1789600000 |
| Sunday, January 1, 2023 | 1060000000 | 2070000000 |
| Monday, January 1, 2024 | 953000000 |
In pursuit of knowledge
In the competitive landscape of the pharmaceutical and biotechnology sectors, United Therapeutics Corporation and Catalent, Inc. have showcased intriguing trends in their gross profits over the past decade. From 2014 to 2023, United Therapeutics consistently outperformed Catalent, with gross profits peaking at approximately $2.07 billion in 2023, marking a significant growth of around 78% from 2014. Meanwhile, Catalent experienced a robust increase of about 77% in the same period, reaching its highest gross profit of approximately $1.64 billion in 2022.
Despite Catalent's impressive growth, United Therapeutics maintained a steady lead, highlighting its strategic prowess in the industry. However, the data for 2024 remains incomplete, leaving room for speculation on future trends. This analysis underscores the dynamic nature of the industry and the importance of strategic financial management.
Gross Profit Comparison: Eli Lilly and Company and United Therapeutics Corporation Trends
Gross Profit Analysis: Comparing Merck & Co., Inc. and United Therapeutics Corporation
Bristol-Myers Squibb Company vs United Therapeutics Corporation: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: GSK plc vs United Therapeutics Corporation
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Who Generates Higher Gross Profit? Takeda Pharmaceutical Company Limited or Catalent, Inc.
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or United Therapeutics Corporation
Biogen Inc. and United Therapeutics Corporation: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? United Therapeutics Corporation or Genmab A/S
Gross Profit Analysis: Comparing United Therapeutics Corporation and Perrigo Company plc
United Therapeutics Corporation vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Catalent, Inc. or Grifols, S.A.